Cellulosic-based interference domain for an analyte sensor

• US 7,651,596 B2
• Filed: 01/18/2006
• Issued: 01/26/2010
• Est. Priority Date: 04/08/2005
• Status: Active Grant

Abstract

The present invention relates generally to devices for measuring an analyte in a host. More particularly, the present invention relates to devices for measurement of glucose in a host that incorporate a cellulosic-based interference domain.

Claims

1. An electrochemical analyte sensor for measuring an analyte in a host, the sensor comprising:

at least one electroactive surface; and

a membrane system disposed on the electroactive surface, wherein the membrane system comprises;

an electrode domain comprising a hydrophilic polymer;

an interference domain disposed more distally from the electroactive surface than the electrode domain and comprising cellulose acetate and cellulose acetate butyrate, wherein the interference domain is configured to resist passage therethrough of at least one interferent, and wherein an equivalent glucose signal response of the at least one interferent is less than about 30 mg/dL;

an enzyme domain disposed more distally from the electroactive surface than the interference domain; and

a resistance domain disposed more distally from the electroactive surface than the enzyme domain, the resistance domain comprising a semipermeable membrane that controls a flux of oxygen and glucose to the underlying enzyme domain.

2. The sensor of claim 1, wherein the equivalent glucose signal response of the at least one interferent is less than about 20 mg/dL.

3. The sensor of claim 1, wherein the equivalent glucose signal response of the at least one interferent is less than about 10 mg/dL.

4. The sensor of claim 1, wherein the equivalent glucose signal response of the at least one interferent is substantially about 0 mg/dL.

5. The sensor of claim 1, wherein the interferent is selected from the group consisting of acetaminophen, ascorbic acid, dopamine, ibuprofen, salicylic acid, tolbutamide, creatinine, uric acid, ephedrine, L-dopa, methyl dopa and tetracycline.

6. The sensor of claim 1, wherein the at least one interferent is selected from the group consisting of ephedrine, tolbutamide and uric acid.

7. The sensor of claim 1, wherein the at least one interferent is selected from the group consisting of acetaminophen, Creatinine, Salicylic acid and Tolazamide.

8. The sensor of claim 1, wherein the at least one interferent is selected from the group consisting of Ascorbic acid, Ibuprofen, and Tetracycline.

9. The sensor of claim 1, wherein the interference domain comprises a layer comprising cellulose acetate and cellulose acetate butyrate.

10. The sensor of claim 1, wherein the interference domain comprises a first layer comprising cellulose acetate butyrate and a second layer comprising cellulose acetate.

11. The sensor of claim 1, wherein the hydrophilic polymer comprises polyvinylpyrrolidone.

12. The sensor of claim 1, wherein the sensor is adapted for subcutaneous insertion.

13. The sensor of claim 1, wherein the sensor is adapted for transcutaneous insertion.

14. The sensor of claim 1, wherein the sensor is adapted for intravascular insertion.

15. A method for forming an electrochemical sensor for measuring an analyte in a host, the method comprising the steps of:

providing at least one electroactive surface;

forming a membrane system on the electroactive surface, wherein the membrane system comprises an interference domain comprising at least one cellulosic derivative and a photoinitiator, wherein the interference domain is configured to resist passage therethrough of interfering species while permitting diffusion therethrough of a measurable species; and

exposing the interference domain to visible light sufficient for substantially crosslinking the interference domain to create covalent bonds but without destroying, delaminating, or significantly breaking down the membrane system and without significantly damaging the at least one electroactive surface, whereby an electrochemical sensor is obtained.

16. The method of claim 15, wherein the exposing step is performed after formation of the interference domain.

17. The method of claim 15, wherein the interference domain is deposited by dip coating at least one layer of the cellulosic derivative over at least a portion of the electroactive surface.

18. The method of claim 17, wherein the cellulosic derivative comprises cellulose acetate butyrate.

19. The method of claim 18, wherein dip coating is from a casting solution or dispersion, wherein the cellulose acetate butyrate comprises from about 15 wt. % to about 25 wt. % of the solution or dispersion.

20. The method of claim 15, further comprising providing at least one film layer that enhances adhesion of the interference domain to another domain of the membrane system.

21. The method of claim 15, wherein the sensor is adapted for subcutaneous insertion.

22. The method of claim 15, wherein the sensor is adapted for transcutaneous insertion.

23. The method of claim 15, wherein the sensor is adapted for intravascular insertion.

24. The method of claim 15, wherein the measurable species is hydrogen peroxide.

25. A glucose sensor configured for insertion into a host for measuring an analyte in the host, the sensor comprising:

a first working electrode having a first electroactive surface located under a first portion of a membrane system comprising an enzyme, wherein the first working electrode is configured to measure a first signal; and

a second working electrode having a second electroactive surface located under a second portion of the membrane system comprising an inactive-enzymatic or a non-enzymatic portion, wherein the second working electrode is configured to measure a baseline signal, wherein the baseline signal is subtracted from the first signal to produce a glucose signal substantially without a baseline component, and wherein the membrane system comprises an interference domain located over both the first and second electroactive surfaces, wherein the interference domain comprises at least one cellulosic derivative configured to substantially restrict, resist, or block a passage of at least one interferent through the interference domain.

26. The sensor of claim 25, wherein the sensor is adapted for subcutaneous insertion.

27. The sensor of claim 25, wherein the sensor is adapted for transcutaneous insertion.

28. The sensor of claim 25, wherein the sensor is adapted for intravascular insertion.

29. The glucose sensor of claim 25, wherein the working electrode is selected from the group consisting of a wire formed from a conductive material, a conductive material deposited onto a substrate, and combinations thereof.

30. The glucose sensor of claim 29, wherein the conductive material is selected from the group consisting of platinum, platinum-iridium, palladium, graphite, gold, carbon, conductive polymer, and alloys thereof.

31. The glucose sensor of claim 25, wherein the first and the second working electrodes are at least partially covered by at least one insulating material selected from the group consisting of a fluorinated polymer, polyethyleneterephthalate, polyurethane, and polyimide.

32. The glucose sensor of claim 25, further comprising a counter electrode and a reference electrode.

33. The glucose sensor of claim 25, wherein the membrane system further comprises an electrode domain, an interference domain, an enzyme domain comprising the enzyme, and a resistance domain.

34. The glucose sensor of claim 33, wherein the electrode domain is more proximal to the first and second electroactive surfaces than the interference domain.

35. The glucose sensor of claim 33, wherein the interference domain is more proximal to the first and second electroactive surfaces than the electrode domain.

36. The glucose sensor of claim 33, wherein the electrode domain comprises polyvinylpyrrolidone.

37. The glucose sensor of claim 33, further comprising at least one film layer configured to enhance adhesion of the interference domain to at least one other domain of the membrane system.

38. The glucose sensor of claim 33, wherein the enzyme domain is more distal from the first and second electroactive surfaces than the interference domain.

39. The glucose sensor of claim 33, wherein the enzyme domain comprises at least one material selected from the group consisting of an aqueous dispersion of colloidal polyurethane polymers, an oxygen enhancing material comprising a silicone, and an oxygen enhancing material comprising a fluorocarbon.

40. The glucose sensor of claim 33, wherein the resistance domain is more distal from the first and second electroactive surfaces than the enzyme domain.

41. The glucose sensor of claim 33, wherein the resistance domain comprises at least one material selected from the group consisting of polyurethanes, polyetherurethaneureas, vinyl polymers, polyethers, polyesters, polyamides, polysiloxanes, polycarbosiloxanes, cellulosic materials, and protein based materials.

42. The glucose sensor of claim 33, wherein the resistance domain comprises a polyurethane membrane with both hydrophilic regions and hydrophobic regions.

43. The glucose sensor of claim 25, wherein the